Kamada (KMDA) EBIT (2012 - 2026)

Kamada (KMDA) posted EBIT of $7.0 million for Q1 2026, down 17.55% on a QoQ basis from $8.4 million in Q4 2025, and down 10.8% year-over-year from $7.8 million in Q1 2025.

Kamada (KMDA) EBIT (2012 - 2026) Analysis & Trends

Kamada's EBIT history runs 15 years deep, the most recent figure standing at $7.0 million for Q1 2026.

  • Quarterly EBIT fell 10.8% year-over-year to $7.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $19.0 billion (up 56529.38% YoY) and the FY2025 annual result came in at $26.2 million, up 30.83% from the prior year.
  • EBIT was $7.0 million for Q1 2026 at Kamada, down from $8.4 million in the prior quarter.
  • Across five years, EBIT topped out at $18.9 billion in Q2 2025 and bottomed at -$2.3 million in Q2 2022.
  • A 5-year average of $1.5 billion and a median of $7.8 million in 2025 frame the typical range for EBIT.
  • Annual changes were most pronounced in 2022 — EBIT sank 319.31% — and 2025, when it jumped 335520.44%.
  • Kamada's EBIT stood at $4.0 million in 2022, then plunged by 30.91% to $2.8 million in 2023, then soared by 268.66% to $10.2 million in 2024, then declined by 17.6% to $8.4 million in 2025, then declined by 17.55% to $7.0 million in 2026.
  • Business Quant data shows KMDA's EBIT at $7.0 million in Q1 2026, $8.4 million in Q4 2025, and $12.3 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT (Qtr)
1 Haleon 88.07 Bn 86.20 Bn - -
2 Teva Pharmaceutical Industries 35.75 Bn 32.01 Bn 1.97 Bn 652.00 Mn
3 Zoetis 31.84 Bn 29.90 Bn 1.62 Bn 833.00 Mn
4 Takeda Pharmaceutical 27.18 Bn 23.12 Bn 4.39 Bn -2.65 Bn
5 United Therapeutics 23.09 Bn 20.93 Bn 648.10 Mn 325.80 Mn
6 RedHill Biopharma 21.32 Bn 21.32 Bn - -
7 Viatris 19.96 Bn 18.16 Bn 1.16 Bn -79.70 Mn
8 Neurocrine Biosciences 17.66 Bn 16.34 Bn 800.70 Mn 193.40 Mn
9 Elanco Animal Health 12.44 Bn 12.02 Bn 785.00 Mn 291.00 Mn
10 Kamada 405.83 Mn 332.68 Mn 19.12 Mn 6.95 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 6.95 Mn
Dec 31, 2025 8.43 Mn
Sep 30, 2025 12.31 Mn
Jun 30, 2025 18.93 Bn
Mar 31, 2025 7.80 Mn
Dec 31, 2024 10.23 Mn
Sep 30, 2024 9.81 Mn
Jun 30, 2024 5.64 Mn
Mar 31, 2024 4.04 Mn
Dec 31, 2023 2.78 Mn
Sep 30, 2023 4.37 Bn
Jun 30, 2023 2.63 Mn
Mar 31, 2023 289.00 Mn
Dec 31, 2022 4.02 Mn
Sep 30, 2022 2.56 Bn
Jun 30, 2022 -2.29 Mn
Mar 31, 2022 246,000.00
Dec 31, 2021 -3.30 Mn
Sep 30, 2021 -804,000.00
Jun 30, 2021 1.05 Mn